
GC68828
Capmatinib Hydrochloride
Also listed as Capmatinib dihydrochloride hydrate
Capmatinib (INC280; INCB28060) dihydrochloride hydrate is an effective, orally active, selective, ATP-competitive c-Met kinase inhibitor (IC50=0·13 nM)· Capmatinib dihydrochloride hydrate can inhibit the phosphorylation of c-MET and downstream effectors such as ERK1/2, AKT, FAK, GAB1 and STAT3/5 in the c-MET pathway· Capmatinib dihydrochloride hydrate effectively inhibits proliferation and migration of c-Met-dependent tumor cells and induces apoptosis· It exhibits anti-tumor activity in mouse models of cancer· Capmatinib dihydrochloride hydrate is mainly metabolized by CYP3A4 and aldehyde oxidase
- CAS number
- 1865733-40-9
- Molecular weight
- 503.36
- Formula
- C23H21Cl2FN6O2
- Solubility
- DMSO : 20·83 mg/mL (41·38 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- COWBUPJEEDYWKD-UHFFFAOYSA-N
- Catalogue number
- GC68828
- Brand
- GLPBIO
Computed properties PubChem CID 122201352 · TPSA 86.1 Ų · H-bond donors 4 · H-bond acceptors 7
- TPSA
- 86.1 Ų
- H-bond donors
- 4
- H-bond acceptors
- 7
- Rotatable bonds
- 4
- Heavy atoms
- 34
SMILES CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F.O.Cl.Cl
Computed descriptors from PubChem (CID 122201352), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il